Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Assets: 2011-2025

Historic Assets for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to $49.3 million.

  • Fennec Pharmaceuticals' Assets fell 16.39% to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.3 million, marking a year-over-year decrease of 16.39%. This contributed to the annual value of $44.9 million for FY2024, which is 67.31% up from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Assets stood at $49.3 million, which was up 9.77% from $44.9 million recorded in Q2 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Assets peaked at $69.2 million during Q1 2024, and registered a low of $15.6 million during Q2 2022.
  • Moreover, its 3-year median value for Assets was $44.9 million (2024), whereas its average is $42.3 million.
  • Its Assets has fluctuated over the past 5 years, first slumped by 44.63% in 2022, then spiked by 224.95% in 2024.
  • Fennec Pharmaceuticals' Assets (Quarterly) stood at $26.0 million in 2021, then climbed by 16.93% to $26.9 million in 2022, then decreased by 0.28% to $26.9 million in 2023, then skyrocketed by 67.31% to $44.9 million in 2024, then decreased by 16.39% to $49.3 million in 2025.
  • Its Assets stands at $49.3 million for Q3 2025, versus $44.9 million for Q2 2025 and $46.4 million for Q1 2025.